also found that silencing of FOXD2-AS1 activates Wnt/β-catenin signaling, affecting cell proliferation, apoptosis, migration and EMT and consequently promoting the progression of HCC. This evidence concerns the gene FOXD2 and hepatocellular carcinoma.